Stay updated with breaking news from Alkermes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
These therapies can improve treatment adherence for patients, especially for those with a history of poor or uncertain adherence.
California State Teachers Retirement System lessened its stake in shares of Alkermes plc (NASDAQ:ALKS – Free Report) by 8.9% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 168,825 shares of the company’s stock after selling 16,559 shares during the quarter. California State Teachers […]
Dublin, Feb. 28, 2024 (GLOBE NEWSWIRE) -- The
Investing.com -- Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: upgrade for Coty, downgrades for Alkermes, and…
UBS Group lowered shares of Alkermes (NASDAQ:ALKS – Free Report) from a neutral rating to a sell rating in a research report released on Tuesday, Marketbeat Ratings reports. The brokerage currently has $25.00 price objective on the stock. Several other analysts have also recently weighed in on the stock. Mizuho decreased their price objective on […]